Insecticides India granted process patent for Acetamiprid
[Editor: Buy Insecticides (India) Ltd (BSE Code: 532851) at CMP of Rs.280-282, for an immediate target of Rs.320. Both the DIIs and FIIs have increased their stake in the company in Q3FY14 as against Q2FY14]
“This was the efforts from the in-house research and development centre. We had filed for the patent with India's Controller General of Patents, Designs & Trademarks for process of preparation for Acetamiprid technical in 2005. Though the process took a longer time, still we are optimistic for our other applications as well. This grant will encourage our team to work further in this direction,” said Rajesh Aggarwal, Managing Director, Insecticides India.
Dr Mukesh, General Manager, R&D and Quality Control, Insecticides India, added, “At IIL, we put a lot of focus on research and development. Our R&D centre at Chopanki in Rajasthan is a testimony to this. The grant for process of preparing Acetamiprid will boost our efforts for further research. We are excited about this achievement and look forward.”
Insecticides India is one of the leading agrochemicals manufacturing company with a top line of Rs 650 crore in last fiscal (2012-13). The company is expected to touch Rs 900 crore this fiscal.
Courtesy: Business Standard
No comments:
Post a Comment